Welcome to our dedicated page for Braskem Sa SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Braskem S.A. (NYSE: BAK) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, giving investors and analysts direct access to official information about this global petrochemical and plastics producer. As a foreign private issuer, Braskem files reports such as Form 20‑F and Form 6‑K, which provide detail on its operations in plastics material and resin manufacturing, its capital structure, and material events affecting the business.
Braskem’s Form 6‑K current reports cover a wide range of topics. Recent filings include notices to shareholders about the date of the annual general meeting, updates on related‑party transactions, and information on contracts that are important to its petrochemical operations. Examples include multi‑year supply agreements with Petróleo Brasileiro S.A. – Petrobras for petrochemical naphtha, polymer‑grade propylene, ethane, and propane, as well as the sale of hydrogen, and a utilities supply agreement for electric power, steam, air, and clarified water at its Camaçari site. These documents help clarify how Braskem secures key feedstocks and services for its manufacturing complexes.
Filings also address capital structure and creditor relations. Braskem has reported on Fitch Ratings’ revision of its global corporate credit rating and on discussions between its subsidiary Braskem Idesa and holders of senior secured notes regarding potential capital structure reorganization proposals. Materials shared with investors under confidentiality agreements and later made public are referenced in these reports, offering additional context on projected prices, supply, costs, and financial indicators used in restructuring analyses.
Other 6‑K submissions include notices on related‑party transactions and treasury share information, as well as disclosures under Brazilian securities regulations about trading in Braskem securities by management, board members, and related persons. These filings support transparency on insider activity and governance practices.
On Stock Titan, each new Braskem filing from the SEC’s EDGAR system is captured and listed, with AI-powered summaries to highlight the main points of lengthy documents. Users can quickly see whether a filing relates to supply contracts, governance and ethics (such as updates to the Code of Conduct), capital markets activity, or creditor negotiations, and then drill down into the full text for deeper analysis. This structure helps investors locate Braskem’s annual and interim reports, current reports on material events, and disclosures about insider trading and related‑party dealings in one organized interface.
Braskem S.A. reports Q3 2025 interim results showing weak profitability and rising balance-sheet pressure. Consolidated net revenue reached R$17,299 million in Q3 and R$54,616 million for the nine months, generating gross profit of R$2,108 million year-to-date but only R$436 million in Q3 as petrochemical margins stayed under pressure. After financial results and taxes, the company posted a Q3 2025 net loss of R$174 million, though it still shows a small nine‑month net profit of R$68 million, with R$405 million attributable to the parent company.
Liquidity tightened meaningfully: consolidated cash and cash equivalents fell from R$14,986 million at year‑end 2024 to R$6,663 million, while operating activities used R$3,300 million of cash in the first nine months. Total borrowings and debentures were R$44,720 million plus R$13,507 million of Braskem Idesa borrowings, leaving consolidated shareholders’ equity negative at R$3,173 million. In response to a tough macro and industry downcycle, Braskem and Braskem Idesa hired financial and legal advisors to evaluate capital structure options, fully drew a US$1.0 billion stand‑by facility in October 2025, and recorded R$784 million of impairment and related charges from mothballing chlorine and caustic soda assets in Alagoas.
Braskem S.A. (BAK) filed a Form 6-K/A reporting Extraordinary General Meeting results. Shareholders approved bylaw changes and elected a new board member. Attendance reached 97.91% of common shares and 75.77% of preferred shares.
Governance updates were approved by majority vote: (i) Lucas Cive Barbosa was elected to the Board of Directors to complete the current term ending at the Annual General Meeting addressing the December 31, 2025 financial statements; (ii) Article 2 was amended to align the corporate purpose with current activities; (iii) a new Article 20 was included to detail slate-based election rules for the Board of Directors; (iv) Article 26 was amended to update Board approval thresholds in line with IPCA inflation, authorize the Board to assess annual updates, and transfer responsibility for selecting and replacing independent auditors of subsidiaries to the Executive Board; and (v) the bylaws were consolidated and renumbered accordingly.
Voting maps show broad support across items, including approvals for the Article 26 update and the consolidation of the bylaws.
Braskem S.A. filed a Form 6-K updating its bylaws to refine corporate governance and decision-making rules. The changes include a detailed list of corporate objectives, new procedures for electing the Board of Directors via slates at shareholder meetings, and updated approval thresholds in Article 27 adjusted by IPCA, with the Board authorized to decide annually on maintaining or monetarily adjusting these thresholds.
The update also removes from the Board of Directors the duty to select and replace independent auditors of the Company’s subsidiaries. The bylaws reaffirm a Board composed of 11 members with at least 20% independent directors, and a permanent five-member Compliance and Audit Committee linked to the Board. Preferred shares keep a minimum, non-cumulative 6% dividend on unit value and shareholders retain a mandatory dividend of 25% of net income under the stated priority and allocation rules.
Braskem S.A. filed a Form 6-K furnishing the detailed final voting map from its Extraordinary General Meeting held on November 13, 2025. The disclosure consolidates voting instructions from remote ballots and in-person votes, listing the first five digits of each shareholder’s taxpayer ID (CPF/CNPJ), their vote on each agenda item, and their shareholding position, as presented in Exhibit I.
The agenda covered governance matters: (1) replacement of one effective Board member appointed by Novonor S.A. – Under Judicial Reorganization and NSP Investimentos S.A. – Under Judicial Reorganization to complete the term until the Annual General Meeting addressing the fiscal year ending December 31, 2025; (2) amendment to Article 2 of the Bylaws to align the corporate purpose with current activities; (3) inclusion of provisions detailing rules and procedures for electing the Board of Directors; (4) amendment to Article 26 to update approval thresholds, authorize the Board to decide on maintenance or monetary adjustment of such thresholds, and remove from the Board the responsibility for selecting and replacing independent auditors of subsidiaries; and (5) consolidation and renumbering of the Bylaws.
Braskem S.A. filed a Form 6‑K furnishing the final synthetic voting map from its Extraordinary General Meeting held on November 13, 2025. Shareholders approved all items, including the replacement of one Board member appointed by Novonor S.A. and NSP Investimentos S.A., to serve until the Annual General Meeting that will resolve the 2025 financial statements.
Governance changes to the Bylaws were also approved: an update to article 2 to align the corporate purpose with current activities; the inclusion of detailed rules for electing the Board of Directors; and an amendment to article 26 to update Board approval thresholds, authorize the Board to maintain or adjust those thresholds, and remove from the Board the responsibility to select and replace independent auditors of subsidiaries. A consolidation of the Bylaws reflecting these changes was approved. Approval levels ranged from 78.1%–80.2% of share capital, including 97.9% of the total number of ordinary shares and 52.3%–57.1% of the total number of preference shares.
Braskem S.A. filed a Form 6-K reporting decisions from its Extraordinary General Meeting. Shareholders approved the replacement of a board member, bylaw updates to clarify the corporate purpose, new rules for electing directors via a slate system, inflation-linked approval thresholds for the Board, and consolidation of the bylaws.
Lucas Cive Barbosa was elected to the Board to replace Roberto Faldini, serving until the Annual General Meeting that will consider the financial statements for the year ending December 31, 2025. Attendance reached 97.91% of common shares and 75.77% of preferred shares.
Key thresholds now explicitly listed include: Board approval for investments above
Braskem S.A. furnished a consolidated summary of remote voting instructions for its Extraordinary General Meeting to be held on November 13, 2025. The statement aggregates instructions received via the stock transfer agent, the B3 central depositary, and directly by the company.
Key items and indicated vote counts included: replacement of one Board member appointed by Novonor/NSP Investimentos, with Approve 27,975,249; Reject 15,201,798; Abstain 44,142. An amendment to article 2 (corporate purpose wording) showed Approve 43,157,938; Reject 43,373; Abstain 19,878. Inclusion of Board election rules had Approve 27,770,686; Reject 15,439,516; Abstain 10,987. Updating article 26 (approval thresholds, authorization to adjust thresholds, and removing auditor selection for subsidiaries from the Board) showed Approve 43,007,735; Reject 179,098; Abstain 34,356. Consolidation of the Bylaws due to these amendments indicated Approve 43,147,187; Reject 54,372; Abstain 19,630.
Braskem S.A. filed a Form 6-K addressing media reports about a potential change of control. The company stated it is not responsible for, nor does it conduct, any negotiations by its shareholder Novonor regarding a possible sale of the controlling stake. Braskem said it is not aware of the information reported and sought clarification from its controlling shareholder.
Novonor informed that, as of November 11, 2025, there have been no material or binding developments in discussions involving its indirect stake in Braskem. Novonor added that any material developments will be promptly communicated to Braskem so the company can take usual measures.
Braskem (BAK) reported Q3 2025 results showing recurring EBITDA of US$150 million, up 104% versus Q2 but below last year as the petrochemical downcycle persisted. Utilization was mixed: Brazil 65%, U.S. & Europe 79%, Mexico 47%, and Green Ethylene 40%. Cash stood at ~US$1.3 billion, and total liquidity was ~US$2.3 billion including a stand-by facility maturing in Dec/26. The company cited higher value‑added sales in Brazil, lower inventory effects in the U.S., and resilience actions to reduce fixed costs.
Debt indicators reflected a stressed cycle: gross debt was US$8.4 billion, adjusted net debt US$7.2 billion, corporate leverage 14.76x, and weighted average cost 6.29%; Fitch rated CCC+ and S&P CCC‑ (Negative) as of Sep/25. Braskem progressed on the Alagoas program, with total provisions of R$18.1 billion and an estimated balance of ~R$3.8 billion at Sep/25, and reported 99.9% of resident relocations completed. In Mexico, the first general maintenance shutdown was completed (investment ~US$75 million) and TQPM ethane supply began (~11.3 kbpd in Sep/25). The Board approved “Transforma Rio,” adding 220 kton/year of ethylene (and equivalent PE) with estimated investment ~R$4.2 billion, targeted for completion by end‑2028, subject to financing and program incentives.
Braskem S.A. (BAK) reported 3Q25 results with consolidated recurring EBITDA of US$150 million (R$818 million), up 104% from 2Q25, amid weak global petrochemical spreads. The Brazil/South America segment delivered US$205 million recurring EBITDA (up 35% q/q), while the United States and Europe posted US$(15) millionUS$(37) million.
The company recorded a net loss of US$1 million in the quarter and YTD net profit of US$66 million. Corporate gross debt was ~US$8.4 billion with an average term of 9 years; cash, excluding Braskem Idesa, was US$1.3 billion, plus a US$1.0 billion revolving line drawn in October. Adjusted net debt ended at US$7.1 billion.
Braskem advanced liability management related to Alagoas: provision balance fell to R$3.8 billion, and a R$1.2 billion State Agreement provides state-level discharge, subject to judicial ratification. The board approved the Transforma Rio project, an estimated R$4.2 billion expansion of ethylene and PE capacity in Rio de Janeiro. During the quarter, ratings moved to the ‘CCC’ range at Fitch and S&P. Sector measures in Brazil included provisional anti-dumping duties on PE imports and maintenance of a 20% import tax on PVC, PE and PP.
FAQ
What is the current stock price of Braskem Sa (BAK)?
What is the market cap of Braskem Sa (BAK)?
